ARCHIVES

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

This article is from The Cancer Letter archive.

Vol. 32 No. 28 | July 21, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities. (8-page issue).

May 2, 2003

SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer

October 28, 2005

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

Obit: Fred Rapp, Penn State Dean And Virologist, Dead At 72.

April 6, 2001